Hadassah

Innovative Treatment at Hadassah Preserves Young Patient’s Heart Without Trauma of Open-Heart Surgery

Tuesday, Mar 19 2013

Thanks to a catheterization method of valve replacement, a 15-year-old girl's life was preserved without the need for open-heart surgery.

The adolescent, who suffers from congestive heart failure, needed to have open-heart surgery every few years to replace a valve that was implanted in her body. When she came to Hadassah for her fourth open-heart surgery, Pediatric Cardiologist Dr. Gavri Sagui suggested that this time, she have a newly renovated valve inserted and sutured through an innovative catheterization procedure. The treatment proved successful and now the young girl will not have to undergo any additional open-heart surgeries. She will just need to have the valve replaced again in 10 years, using the same minimally invasive procedure.

"The physical and mental traumas following each surgery were very difficult," the girl's mother said. "This time there was no trauma at all, and she even wrote a book of optimistic poems about her experience."

Dr. Sagui explains that the new procedure enables the patient to go back home within a few days. "The only thing that is left," he says, "is a small incision in the foot."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More